A study by Thommen et al. [53] revealed that increased coexpression of CTLA-4, PD-1, TIM-3, LAG-3 as well as BTLA, was positively related to progressive T-cell exhaustion and subsequent resistance to anti-PD1 therapy in NSCLC. Here, HAVCR2 is linked to non-small cell lung carcinoma.